These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 6949052)
1. Use of lisuride in advanced Parkinson's disease. Potent dopamine and serotonin agonist. Lieberman AN; Goldstein M; Neophytides A; Leibowitz M; Gopinathan G; Goodgold A; Pact V; Walker R N Y State J Med; 1981 Nov; 81(12):1751-5. PubMed ID: 6949052 [No Abstract] [Full Text] [Related]
2. [Oral lisuride in Parkinson's disease]. Obeso JA; Luquin MR; Martínez Lage JM Med Clin (Barc); 1985 Sep; 85(8):307-12. PubMed ID: 4068822 [No Abstract] [Full Text] [Related]
3. [Lisuride in the combination treatment of Parkinson disease]. Jellinger K Wien Med Wochenschr; 1987 Apr; 137(7-8):155-9. PubMed ID: 3111099 [TBL] [Abstract][Full Text] [Related]
4. Pergolide and lisuride in advanced Parkinson's disease. Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Goldstein M Adv Neurol; 1984; 40():503-7. PubMed ID: 6695627 [TBL] [Abstract][Full Text] [Related]
5. Comparison of efficacy of lisuride hydrogen maleate with increased doses of levodopa in parkinsonian patients. Rabey JM; Treves T; Streifler M; Korczyn AD Adv Neurol; 1987; 45():569-72. PubMed ID: 3825734 [No Abstract] [Full Text] [Related]
6. Intravenous lisuride corrects oscillations of motor performance in Parkinson's disease. Obeso JA; Luquin MR; Martínez Lage JM Ann Neurol; 1986 Jan; 19(1):31-5. PubMed ID: 3947037 [TBL] [Abstract][Full Text] [Related]
7. Continuous dopaminergic stimulation in the management of complicated Parkinson's disease. Agnoli A; Stocchi F; Carta A; Antonini A; Bragoni M; Ruggieri SA Mt Sinai J Med; 1988 Jan; 55(1):62-6. PubMed ID: 3258057 [No Abstract] [Full Text] [Related]
8. Therapeutic effect of lisuride in advanced Parkinson's disease. Meneghetti G; Bracco F; Giometto B; Ferla S; Schergna E Eur Neurol; 1986; 25(1):74-80. PubMed ID: 3510126 [TBL] [Abstract][Full Text] [Related]
9. The use of lisuride in severe Parkinson's disease. Chin D; Yu YL; Huang CY Clin Exp Neurol; 1986; 22():63-9. PubMed ID: 3581512 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of terguride in patients with Parkinson's disease. Suchy I; Rinne UK; Wachtel H Adv Neurol; 1987; 45():577-81. PubMed ID: 3548267 [No Abstract] [Full Text] [Related]
11. Use of ergot derivative lisuride in Parkinson's disease. Suchy I; Horowski R Adv Neurol; 1984; 40():515-21. PubMed ID: 6695629 [No Abstract] [Full Text] [Related]
12. Lisuride and pergolide in Parkinson's disease. Lang AE; Sheehy MP; Quinn NP; Brincat S; Marsden CD; Parkes D Adv Neurol; 1983; 37():109-20. PubMed ID: 6858769 [No Abstract] [Full Text] [Related]
13. Lisuride in Parkinson disease: efficacy of lisuride compared to levodopa. Lieberman A; Goldstein M; Neophytides A; Kupersmith M; Leibowitz M; Zasorin N; Walker R; Kleinberg D Neurology; 1981 Aug; 31(8):961-5. PubMed ID: 7022259 [TBL] [Abstract][Full Text] [Related]
14. Lisuride, a dopamine agonist in the treatment of early Parkinson's disease. Rinne UK Neurology; 1989 Mar; 39(3):336-9. PubMed ID: 2927639 [TBL] [Abstract][Full Text] [Related]
15. Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studies. LeWitt PA; Burns RS; Calne DB Adv Neurol; 1983; 37():131-40. PubMed ID: 6344586 [TBL] [Abstract][Full Text] [Related]